Literature DB >> 24145109

Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.

Madhura Kulkarni Chitnis1, Ya Fatou Njie-Mbye, Catherine A Opere, Mark E Wood, Matthew Whiteman, Sunny E Ohia.   

Abstract

Hydrogen sulfide (H2S), a colorless gas characterized by its pungent odor of rotten eggs has been reported to elicit relaxation effects on basal and pre-contracted non-ocular smooth muscles of several mammalian species. In the present study, we investigated the pharmacological actions of a H2S donor, GYY4137 on isolated bovine posterior ciliary artery after contraction with the adrenergic receptor agonist, phenylephrine. Furthermore, we studied the underlying mechanism of inhibitory action of GYY4137 on the posterior ciliary arteries. Isolated bovine posterior ciliary arteries were mounted in oxygenated organ baths and changes in isometric tension were measured with a Grass FT03 transducer connected to a recorder using a Grass Polyview Software. The relaxant actions of GYY4137 on phenylephrine pre-contracted arteries were observed in the absence and presence of an inhibitor of cyclo-oxygenase, flurbiprofen. Furthermore, the inhibitory effects of GYY4137 were studied in the absence or presence of inhibitors/activators of biosynthetic enzymes for H2S and nitric oxide production, as well as specific ion channel blockers. In the concentration range, 100 nM to 100 μM, GYY4137 elicited a concentration-dependant relaxation of phenylephrine-induced tone in isolated posterior ciliary arteries, with IC50 value of 13.4 ± 1.9 μM (n = 6). The cyclo-oxygenase inhibitor, flurbiprofen, significantly (p < 0.01) enhanced the relaxation induced by GYY4137 yielding IC50 value of 0.13 ± 0.08 μM (n = 6). Both the inhibitors of cystathionine β-synthase (aminooxyacetic acid, AOAA, 30 μM) and cystathionine γ-lyase (propargylglycine, PAG, 1 mM) caused significant (p < 0.05) rightward shifts in the concentration-response curve to GYY4137. Furthermore, the KATP channel antagonist, glibenclamide (100 μM) significantly (p < 0.01) attenuated the relaxant action induced by GYY4137 on bovine ciliary artery. Conversely, the activator of cystathionine β-synthase, SAM (100 μM) and an inhibitor of nitric oxide synthase, L-NAME (100 μM) had no significant effect on relaxations induced by GYY4137. We conclude that the inhibitory action of GYY4137 on isolated bovine ciliary artery is dependent upon the endogenous production of both prostanoids and H2S. Furthermore, the observed vascular smooth muscle relaxation induced by GYY4137 is mediated, at least in part, by KATP channels. Published by Elsevier Ltd.

Entities:  

Keywords:  AOAA; CBS; COX; CSE; GYY4137; H(2)S; NaSH; PAG; PCA; S-adenosyl-l-methionine; SAM; aminooxyacetic acid; bovine posterior ciliary artery; cyclo-oxygenase; cystathionine β-synthase; cystathionine γ-lyase; hydrogen sulfide; l-NAME; l-nitroarginine methyl ester; posterior ciliary arteries; propargylglycine; prostanoids; sodium hydrosulfide

Mesh:

Substances:

Year:  2013        PMID: 24145109     DOI: 10.1016/j.exer.2013.10.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  20 in total

Review 1.  Vascular biology of hydrogen sulfide.

Authors:  Nancy L Kanagy; Csaba Szabo; Andreas Papapetropoulos
Journal:  Am J Physiol Cell Physiol       Date:  2017-02-01       Impact factor: 4.249

2.  Inhibitory action of novel hydrogen sulfide donors on bovine isolated posterior ciliary arteries.

Authors:  Madhura Kulkarni-Chitnis; Ya Fatou Njie-Mbye; Leah Mitchell; Jenaye Robinson; Matthew Whiteman; Mark E Wood; Catherine A Opere; Sunny E Ohia
Journal:  Exp Eye Res       Date:  2015-04-04       Impact factor: 3.467

3.  Evidence for a functional vasodilatatory role for hydrogen sulphide in the human cutaneous microvasculature.

Authors:  Jessica L Kutz; Jody L Greaney; Lakshmi Santhanam; Lacy M Alexander
Journal:  J Physiol       Date:  2015-03-25       Impact factor: 5.182

4.  Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo.

Authors:  Jenaye Robinson; Esther Okoro; Chinoso Ezuedu; Leah Bush; Catherine A Opere; Sunny E Ohia; Ya Fatou Njie-Mbye
Journal:  J Ocul Pharmacol Ther       Date:  2017-01-18       Impact factor: 2.671

5.  Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Authors:  Pratik Bankhele; Ankita Salvi; Jamal Jamil; Fatou Njie-Mbye; Sunny Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2018-01-20       Impact factor: 3.996

Review 6.  Hydrogen Sulfide-Induced Vasodilation: The Involvement of Vascular Potassium Channels.

Authors:  Xiao-Yu Liu; Ling-Ling Qian; Ru-Xing Wang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 7.  Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.

Authors:  Sunny E Ohia; Jenaye Robinson; Leah Mitchell; Kalu K Ngele; Segewkal Heruye; Catherine A Opere; Ya Fatou Njie-Mbye
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-07       Impact factor: 2.671

8.  Effect of Hydrogen Sulfide Donors on Intraocular Pressure in Rabbits.

Authors:  Ankita Salvi; Pratik Bankhele; Jamal Jamil; Madhura Kulkarni Chitnis; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-19       Impact factor: 2.671

9.  Pharmacological Actions of Hydrogen Sulfide Donors on Sympathetic Neurotransmission in the Bovine Anterior Uvea, In Vitro.

Authors:  Ankita Salvi; Pratik Bankhele; Jamal M Jamil; Madhura Kulkarni-Chitnis; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

Review 10.  Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.

Authors:  Guoliang Meng; Yan Ma; Liping Xie; Albert Ferro; Yong Ji
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.